These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 9932731

  • 1. Kappa1-opioid binding sites are the dominant opioid binding sites in surgical specimens of human pheochromocytomas and in a human pheochromocytoma (KAT45) cell line.
    Kampa M, Margioris AN, Hatzoglou A, Dermitzaki I, Denizot A, Henry JF, Oliver C, Gravanis A, Castanas E.
    Eur J Pharmacol; 1999 Jan 08; 364(2-3):255-62. PubMed ID: 9932731
    [Abstract] [Full Text] [Related]

  • 2. The antiproliferative effect of opioid receptor agonists on the T47D human breast cancer cell line, is partially mediated through opioid receptors.
    Hatzoglou A, Bakogeorgou E, Castanas E.
    Eur J Pharmacol; 1996 Jan 25; 296(2):199-207. PubMed ID: 8838457
    [Abstract] [Full Text] [Related]

  • 3. Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum.
    Schoffelmeer AN, Hogenboom F, Mulder AH.
    Br J Pharmacol; 1997 Oct 25; 122(3):520-4. PubMed ID: 9351509
    [Abstract] [Full Text] [Related]

  • 4. Evidence for mu-, delta-, and kappa-opioid receptors in a human neuroblastoma cell line.
    Baumhaker Y, Wollman Y, Goldstein MN, Sarne Y.
    Life Sci; 1993 Oct 25; 52(19):PL205-10. PubMed ID: 8387137
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The bovine mu-opioid receptor: cloning of cDNA and pharmacological characterization of the receptor expressed in mammalian cells.
    Onoprishvili I, Andria ML, Vilim FS, Hiller JM, Simon EJ.
    Brain Res Mol Brain Res; 1999 Nov 10; 73(1-2):129-37. PubMed ID: 10581406
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Binding properties of C-truncated delta opioid receptors.
    Wang CH, Zhou DH, Chen J, Li GE, Pei G, Chi ZQ.
    Zhongguo Yao Li Xue Bao; 1997 Jul 10; 18(4):337-40. PubMed ID: 10072917
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Sodium regulation of agonist binding at opioid receptors. II. Effects of sodium replacement on opioid binding in guinea pig cortical membranes.
    Werling LL, Brown SR, Puttfarcken P, Cox BM.
    Mol Pharmacol; 1986 Aug 10; 30(2):90-5. PubMed ID: 3016504
    [Abstract] [Full Text] [Related]

  • 14. The effects of postmortem delay on mu, delta and kappa opioid receptor subtypes in rat brain and guinea pig cerebellum evaluated by radioligand receptor binding.
    Paul D, Gauthier CA, Minor LD, Gonzales GR.
    Life Sci; 1997 Aug 10; 61(20):1993-8. PubMed ID: 9366506
    [Abstract] [Full Text] [Related]

  • 15. Role of protein kinase C (PKC) in agonist-induced mu-opioid receptor down-regulation: I. PKC translocation to the membrane of SH-SY5Y neuroblastoma cells is induced by mu-opioid agonists.
    Kramer HK, Simon EJ.
    J Neurochem; 1999 Feb 10; 72(2):585-93. PubMed ID: 9930730
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.